GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

Similar documents
Refeeding syndrome a practical approach

Acute management of severe malnutrition. Dr Simon Gabe St Mark s Hospital, London

Prevention of Electrolyte Disorders Refeeding Syndrome พญ.น นทพร เต มพรเล ศ

Formulary and Prescribing Guidelines

Refeeding Syndrome Guideline

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults

MANAGEMENT AND PREVENTION OF REFEEDING SYNDROME IN INPATIENTS: A PRACTICAL APPROACH

Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome)

Does the patient need an enteral feed out of hours?

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

TOTAL PARENTERAL NUTRITION

Title The Prescription of Adult Inpatient Parenteral Nutrition (PN) Guideline. Author s job title Consultant Gastroenterologist Directorate Medicine

BNF 9: Blood and Nutrition

Dutch consensus statement on Refeeding syndrome

Glutaric aciduria type 1 (GA1) Dietetic Management Pathway

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE

Refeeding Low Weight Adolescents with AN

NUTRITION. Elizabeth Viner Smith & Catherine Jones Foundations of Critical Care Nursing September 2017

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA

Guidelines for managing adults at risk of refeeding syndrome.

A Guide to Prescribing Adult Oral Nutritional Supplements in West Kent CCG

Nutritional management of eating disorders. Louise Watson Clinical Dietitian South Island Eating Disorders Service

Nutrition in Pancreatic Cancer. Edmond Sung Consultant Gastroenterologist Lead Clinician for Clinical Nutrition and Endoscopy

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist

Intensive Care Nutrition. Dr Alan Race BSc(Hons) PhD FRCA

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Bangladesh Breastfeeding Foundation

INTRAVENOUS FLUID THERAPY

Weekly Cisplatin + Radiotherapy - Interlace study -

PARENTERAL NUTRITION

Basic Fluid and Electrolytes

ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION

Policy Compliance Procedure

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

Over-feeding and over- hydration in elderly medical patients Lessons from the Liverpool Care Pathway. Correspondence to: Abstract Keywords

Gemcitabine + Cisplatin Regimen

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

Tumour Lysis Syndrome (TLS)

6-7 JULY 2015, BIRMINGHAM CONGRESS

Insulin Tolerance Test Protocol - RNS Endocrinology

Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter

INTRAVENOUS FLUIDS PRINCIPLES

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Electrolyte Disorders in ICU. Debashis Dhar

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

Package leaflet: Information for the patient

NUTRITIONAL REQUIREMENTS

PATIENTS PRESENTING WITH SUSPECTED OR CONFIRMED ANOREXIA NERVOSA

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021

ECX. Anti-emetics: Day 1: highly emetogenic Days 2 21: mildly emetogenic

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy

Paediatric Best Practice Guidelines. Eating Disorders

Guidelines for the Prevention and Management of Hypoglycaemia

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

DRUG ALLERGIES WT: KG

Inflammatory Bowel Disease

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Pediatric Dehydration and Oral Rehydration. May 16/17

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Fluid therapy in children

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

Case Study: Nutritional management of a patient at high risk of developing refeeding syndrome

5-FU & Cisplatin + Cetuximab

Electrolytes Solution

SECTION 15: TREATMENT OF EATING DISORDERS. Formulary and Prescribing Guidelines

Cisplatin / Capecitabine (+ Trastuzumab) in Gastric Cancer

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Dr Roger Morgan. Psychiatrist Princess Margaret Hospital Christchurch

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

Chapter 9 Nutrition and Blood

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs.

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

STANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS

Gemcitabine & Cisplatin

SUMMARY OF PRODUCT CHARACTERISTICS

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults

Refeeding syndrome: An overlooked condition?

Nutritional support on the Acute Medical Unit. Acute Medicine Conference 2017

PHARMACOLOGY AND PHARMACOKINETICS

Long term monitoring. Dr Alison Culkin Research Dietitian St Mark s Hospital

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes

Bevacizumab + Paclitaxel + Cisplatin

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 October 2011

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

Supplementary Table 1. Patient demographics and baseline characteristics (treated patients).

Diabetes Labour guideline (GL820)

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!

Targeted Employees/ Departments: Clinical Nutrition Department, Food Services Department, Catering Services, Nursing Department and Physicians

DERBY-BURTON LOCAL CANCER NETWORK FILENAME R-CODOX-M.DOC CONTROLLED DOC NO: HCCPG B115 CSIS Regimen Name: R-CODOXM. Rituximab + CODOX-M

BNF CHAPTER 9: NUTRITION & BLOOD

Unit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration

Vitamin and Mineral Supplementation and Monitoring. Bariatric Surgery

PRODUCT INFORMATION RESONIUM A. Na m

Transcription:

When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032 available from web site) Remember: - Oral feeding is simpler and safer than artificial methods - Give small amounts frequently (3-4 hourly) - Intake should be limited at first and increased slowly - Weekly weight gain of 0.5 1.0 kg generally regarded as optimum Step 1. Decide whether patient is at high or normal risk of re-feeding: The patient is at high risk if they have One or more of the following: - BMI less than 16 kg/m2 - Unintentional weight loss greater than 15% within the last 3 6 months - little or no nutritional intake for more than 10 days - low levels of potassium, phosphate or magnesium prior to feeding. Two or more of the following: - BMI less than 18.5 kg/m2 - Unintentional weight loss greater than 10% within the last 3 6 months - little or no nutritional intake for more than 5 days - a history of alcohol abuse or drugs including insulin, chemotherapy, antacids or diuretics. Step 2. Decide rate of re-feeding: - If normal risk, start nutrition support at a maximum of 10 kcal/kg/day, increasing levels slowly to meet or exceed full needs by 4 7 days (see sample meal plans) If normal risk: number of kcals to be given / day: Weight Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 on Adm. 30 kg 300 500 800 1000 1200 1400 1600 35 kg 400 600 800 1000 1200 1400 1600 40 kg 400 600 800 1000 1200 1400 1600 45 kg 400 600 800 1000 1200 1400 1600 50 kg 500 800 1000 1200 1400 1600 1600 55 kg 500 800 1000 1200 1400 1600 1600 60 kg 600 800 1000 1200 1400 1600 1600

- If high risk, commence feeding at only 5 kcal/kg/day in extreme cases (see sample meal plans) - Restore circulatory volume and monitoring fluid balance and overall clinical status closely If High risk: number of kcals to be given / day: Weight Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 on Adm. 30 kg 150 300 500 800 1000 1200 1400 35 kg 200 400 600 800 1000 1200 1400 40 kg 200 400 600 800 1000 1200 1400 45 kg 200 400 600 800 1000 1200 1400 50 kg 300 500 800 1000 1200 1400 1600 55 kg 300 500 800 1000 1200 1400 1600 60 kg 300 500 800 1000 1200 1400 1600 Step 3. Before and during the first 10 days of feeding: - Oral thiamin 200 300 mg daily, - Vitamin B co strong 1 or 2 tablets, three times a day (or full dose daily intravenous vitamin B preparation, if necessary) (i.e one pair of Pabrinex IV high potency ampoules. Ensure facilities for treating anaphylylaxis are available during administration). - A balanced multivitamin/trace element supplement once daily e.g. Forceval 1 x capsule daily - Provide oral, enteral or intravenous supplements of potassium (likely requirement 2 4 mmol/kg/day), phosphate (likely requirement 0.3 0.6 mmol/kg/day) and magnesium (likely requirement 0.2 mmol/kg/day intravenous, 0.4 mmol/kg/day oral) unless pre-feeding plasma levels are high. - Pre-feeding correction of low plasma levels is unnecessary. Step 4. Correction of Electrolyte Disturbances: (see over) - Biochemical monitoring should guide need for replacement - Electrolytes may change rapidly during first week - Can be replaced orally or intravenously (if absolutely necessary and with caution) - Electrolytes are closely inter-related - Hypo-magnesaemia may cause hypo-kalaemia - Replacement of phosphate may cause calcium to drop Detailed guidance on electrolyte replacement in: Guidelines for the nutritional management of anorexia nervosa (Royal College of Psychiatrists, 2005)

Micronutrient Supplements: - Micronutrient supplement recommended in both in-patients and outpatients - Forceval or Sanatogen Gold (non-nhs) - Compound preparations may not contain enough thiamin to meet metabolic demands of re-feeding - Oral thiamin (25-50 mg/day) recommended for in-patients and outpatients undergoing rapid weight gain Suggested replacement therapy in a depleted patient: Phosphate Correction If <0.30mmol/l and renal function/ calcium levels are normal, correct using Phosphate Polyfusor (contains 50mmol phosphate in 500mls). Maximum rate of 9mmol of phosphate over 12hrs (faster rates may be given in ITU), therefore 90ml of Phosphate Polyfusor in 12hrs, administer at 7.5ml/hour (total of 180mls). Re-check phosphate levels daily and repeat above infusion if levels remain <0.30mmol/l. If levels are between 0.30mmol/l - 0.5mmol/l, administer 3 tablets daily (maximum) of Phosphate-Sandoz via the enteral route. Potassium Correction If < 3mmol/l, correct using 1litre of saline and 40mmol of K per litre, over a minimum of 2 hours If levels are between 3-3.5mmol/l, administer Sando K, one tablet three times a day. Magnesium Correction If <0.5mmol/l, correct using 10ml of Magnesium Sulphate 50% (contains 20mmol magnesium) in 100ml of suitable fluid (e.g. sodium chloride 0.9%) over a minimum of 2½ hours. Oral preparations are generally not recommended due to tolerance and side effects of large doses. Average deficit in symptomatic magnesium deficiency is 1mmol/kg (can replace up to 50mmol a day). Monitor levels and repeat once daily until levels >0.5mmol/l.

Step 5. Feed as per meal plan. - Contact Dietitian if there are any problems, questions or if you would like any further information re: the above Step 6. Dietitian will aim to review patient in person as soon as possible

Time Frame for Re-feeding Treat or prevent: Hypoglycaemia Hypothermia Dehydration Correct electrolyte imbalance Days 1-2 Days 3-7 Weeks 2-6 Weeks 7 Correct micronutrient deficiencies Begin feeding Increase feeding to recover lost weight without iron with iron